Comprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigation.
Oncotarget
Vigneswaran, Janani J; Tan, Yi-Hung Carol YH; Murgu, Septimiu D SD; Won, Brian M BM; Patton, Kathryn Alexa KA; Villaflor, Victoria M VM; Hoffman, Philip C PC; Hensing, Thomas T; Hogarth, D Kyle DK; Malik, Renuka R; MacMahon, Heber H; Mueller, Jeffrey J; Simon, Cassie A CA; Vigneswaran, Wickii T WT; Wigfield, Christopher H CH; Ferguson, Mark K MK; Husain, Aliya N AN; Vokes, Everett E EE; Salgia, Ravi R